Table 4 Clinical outcome at 5-year follow-up
Outcome | Time-of-day | p-value | |||
|---|---|---|---|---|---|
0–6 h | 6–12 h | 12–18 h | 18–24 h | ||
All-cause mortality | 28 (13.6) | 24 (8.7) | 31 (13.7) | 21 (9.3) | 0.30 |
Cardiac mortality | 19 (9.0) | 12 (4.3) | 22 (9.7) | 15 (6.4) | 0.13 |
Myocardial infarction | 9 (3.4) | 15 (5.0) | 11 (5.0) | 6 (2.2) | 0.60 |
Target vessel revascularization | 59 (23.4) | 94 (30.4) | 69 (24.6) | 67 (26.8) | 0.40 |
Major adverse cardiovascular events | 81 (33.5) | 117 (38.0) | 95 (36.2) | 83 (32.6) | 0.80 |